Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

0(0%)

Results Posted

50%(1 trials)

Terminated

1(25%)

Phase Distribution

Ph phase_3

25%

Ph phase_2

75%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

3(75.0%)

Phase 3Large-scale testing

1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Terminated(1)

Other(1)

Detailed Status

Completed2

Terminated1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 3

Trials by Phase

Phase 23 (75.0%)

Phase 31 (25.0%)

Trials by Status

terminated125%

unknown125%

completed250%

Recent Activity

0 active trials

Showing 4 of 4

unknownphase_2

Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis Patients

NCT03084952

completedphase_3

Efficacy and Safety of Miltefosine or Thermotherapy for Cutaneous Leishmaniasis in Colombia.

NCT00471705

terminatedphase_2

Safety and Efficacy of Azithromycin to Treat Cutaneous Leishmaniasis

NCT00682656

completedphase_2

Allopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil

NCT00004755

Clinical Trials (4)

Showing 4 of 4 trials

NCT03084952Phase 2

Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis Patients

Unknown

NCT00471705Phase 3

Efficacy and Safety of Miltefosine or Thermotherapy for Cutaneous Leishmaniasis in Colombia.

Completed

NCT00682656Phase 2

Safety and Efficacy of Azithromycin to Treat Cutaneous Leishmaniasis

Terminated

NCT00004755Phase 2

Allopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil

Completed

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4